| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01246674 |
| P8608 | Fatcat ID | release_rqx3wtszejg4loy4kribu64wjy |
| P698 | PubMed publication ID | 7927537 |
| P2093 | author name string | G R Sutherland | |
| E Baker | |||
| C A Abbott | |||
| G W McCaughan | |||
| P2860 | cites work | Direct association of adenosine deaminase with a T cell activation antigen, CD26 | Q24322080 |
| Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 | Q28288094 | ||
| Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
| Human N-myc is closely related in organization and nucleotide sequence to c-myc | Q28299447 | ||
| Oligopeptidases, and the emergence of the prolyl oligopeptidase family. | Q33203029 | ||
| A transcription factor active on the epidermal growth factor receptor gene | Q33631334 | ||
| Reassessment of two apparent deletions of chromosome 16p to an ins(11;16) and a t(1;16) by chromosome painting | Q33721821 | ||
| Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface | Q34243428 | ||
| Proline specific endo- and exopeptidases | Q34274964 | ||
| Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. | Q34668282 | ||
| Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain. | Q35551432 | ||
| Lung endothelial dipeptidyl peptidase IV is an adhesion molecule for lung-metastatic rat breast and prostate carcinoma cells | Q36233008 | ||
| The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity | Q36306512 | ||
| A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase | Q36361511 | ||
| Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function | Q37409296 | ||
| Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene | Q37524558 | ||
| Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence | Q37585633 | ||
| CD26: a surface protease involved in T-cell activation | Q39005893 | ||
| The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter | Q40644672 | ||
| Proline-dependent structural and biological properties of peptides and proteins | Q40881554 | ||
| T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells | Q41508169 | ||
| Cloning and functional expression of the T cell activation antigen CD26. | Q41613870 | ||
| Identification of the active site residues in dipeptidyl peptidase IV by affinity labeling and site-directed mutagenesis | Q41635450 | ||
| Isolation of a cDNA probe for the human intestinal dipeptidylpeptidase IV and assignment of the gene locus DPP4 to chromosome 2. | Q41729783 | ||
| The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity | Q41737323 | ||
| A monoclonal antibody detecting dipeptidylpeptidase IV in human tissue | Q41771539 | ||
| Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family | Q41826756 | ||
| Proteins of the kidney microvillar membrane. Reconstitution of endopeptidase in liposomes shows that it is a short-stalked protein | Q42167179 | ||
| SIGNAL SCAN: a computer program that scans DNA sequences for eukaryotic transcriptional elements | Q44538605 | ||
| Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo | Q44727485 | ||
| Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. | Q48372152 | ||
| Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases. | Q55065890 | ||
| Studies on glycyl-proline naphthylamidase. I. Lymphocytes | Q67053429 | ||
| Genetics of melanoma | Q67253323 | ||
| Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs | Q67519406 | ||
| Prolyl endopeptidase and dipeptidyl peptidase IV are distantly related members of the same family of serine proteases | Q67884959 | ||
| Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways | Q68088070 | ||
| Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation | Q68163822 | ||
| The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta | Q68170404 | ||
| Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes | Q68295551 | ||
| Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes | Q68303270 | ||
| Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations | Q69056953 | ||
| Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody | Q72739500 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 331-338 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Immunogenetics | Q15709984 |
| P1476 | title | Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene | |
| P478 | volume | 40 |
| Q57975973 | A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma |
| Q37402676 | Adenosine neuromodulation and traumatic brain injury |
| Q38556037 | An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus |
| Q73039660 | Analysis of dipeptidyl peptidase IV gene regulation in transgenic mice: DNA elements sufficient for promoter activity in the kidney, but not the intestine, reside on the proximal portion of the gene 5'-flanking region |
| Q26785454 | Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes |
| Q38937243 | CD26 and Asthma: a Comprehensive Review. |
| Q33702158 | CD26, let it cut or cut it down. |
| Q34383575 | Cardiovascular impact of drugs used in the treatment of diabetes |
| Q35818705 | Cell-surface peptidases |
| Q45148667 | Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells |
| Q37984567 | Clinical pharmacokinetics and pharmacodynamics of vildagliptin |
| Q24290340 | Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8 |
| Q40179567 | Cluster analysis and phylogenetic relationship in biomarker identification of type 2 diabetes and nephropathy |
| Q36799402 | Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome |
| Q36617545 | Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. |
| Q38751579 | Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system |
| Q57316296 | DPP4 Gene DNA Methylation in the Omentum is Associated With Its Gene Expression and Plasma Lipid Profile in Severe Obesity |
| Q35107619 | DPPIV, seprase, and related serine peptidases in multiple cellular functions |
| Q73619619 | Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status |
| Q37359802 | Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema |
| Q36735761 | Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug |
| Q33788748 | Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides |
| Q35189265 | Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. |
| Q43476772 | Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis |
| Q61810243 | Enhancement of the Stability and Anti-DPPIV Activity of Hempseed Hydrolysates Through Self-Assembling Peptide-Based Hydrogels |
| Q71819320 | Enzymatic activity of DPIVCD26 is involved in PMA-induced hyperphosphorylation of p56lck |
| Q92001025 | Extracellular signaling in Dictyostelium |
| Q28082504 | Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review) |
| Q60617867 | Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis |
| Q38207948 | GLP-1R activation for the treatment of stroke: updating and future perspectives |
| Q36717067 | High Levels of Serum DPP-4 Activity Are Associated with Low Bone Mineral Density in Obese Postmenopausal Women. |
| Q42822338 | Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter |
| Q35097139 | Identification and partial characterization of the enzyme of omega: one of five putative DPP IV genes in Drosophila melanogaster |
| Q28143125 | Identification of an alternatively spliced seprase mRNA that encodes a novel intracellular isoform |
| Q24336366 | Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease |
| Q73419681 | Induction of interleukin-1 and glucocorticoid hormones by HIV promotes viral replication and links human chromosome 2 to AIDS pathogenesis: genetic mechanisms and therapeutic implications |
| Q99568814 | Integration of microarray data and literature mining identifies a sex bias in DPP4+CD4+ T cells in HIV-1 infection |
| Q37941683 | Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus |
| Q41525016 | Milk protein-derived opioid receptor ligands |
| Q24321533 | Molecular cloning of seprase: a serine integral membrane protease from human melanoma |
| Q39552169 | Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations |
| Q43104954 | N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. |
| Q33593227 | Peptidases: structure, function and modulation of peptide-mediated effects in the human lung |
| Q32092553 | Phage-displayed mimotopes elicit monoclonal antibodies specific for a malaria vaccine candidate. |
| Q42997344 | Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes |
| Q38248682 | Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors |
| Q91863504 | Physiologically based pharmacokinetic model of the DPP-4 inhibitor linagliptin to describe its nonlinear pharmacokinetics in humans |
| Q41684848 | Proline specific peptidases |
| Q38833194 | Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson's disease: historical overview and future prospects |
| Q33692975 | Proteins expressed by pancreatic duct cells and their relatives |
| Q57662605 | Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q35192179 | Response to the dipeptidyl peptidase-4 inhibitors in Japanese patients with type 2 diabetes might be associated with a diplotype of two single nucleotide polymorphisms on the interleukin-6 promoter region under a certain level of physical activity |
| Q28583352 | Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity |
| Q35905508 | Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) |
| Q58784788 | Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum |
| Q47938434 | Structure and localization of the mouse prolyl oligopeptidase gene |
| Q38847322 | Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice. |
| Q34648201 | Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes |
| Q60617869 | Two highly conserved glutamic acid residues in the predicted β propeller domain of dipeptidyl peptidase IV are required for its enzyme activity |
| Q44919467 | Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV. |
| Q38210234 | Understanding the molecular dynamics of type-2 diabetes drug target DPP-4 and its interaction with Sitagliptin and inhibitor Diprotin-A. |
| Q53807699 | [Dipeptidyl peptidase IV in inflammatory bowel diseases (DPP IV/CD26)]. |
| Q83656427 | [Safety and tolerability of oral antidiabetes drugs in the treatment of type 2 diabetes mellitus] |
Search more.